A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
Clinical trial NCT00391222 · COMPLETED
Trial details
- NCT number
- NCT00391222
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-04-01
- Enrollment
- 585
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.